CMP-001-011
Clinical Trial Grant
Administered By
Duke Cancer Institute
Awarded By
Checkmate Pharmaceuticals
Start Date
November 16, 2020
End Date
January 10, 2026
Administered By
Duke Cancer Institute
Awarded By
Checkmate Pharmaceuticals
Start Date
November 16, 2020
End Date
January 10, 2026